May 14 |
Optinose Reports First Quarter 2024 Financial ResultsĀ and Recent Operational Highlights
|
May 10 |
OptiNose Inc (OPTN) Announces $55 Million Financing Round Amidst Revenue Projections
|
May 10 |
Optinose Announces Reporting Date for First Quarter 2024 Financial Results
|
May 9 |
Optinose Announces $55 Million Registered Direct Offering
|
May 5 |
Recent uptick might appease OptiNose, Inc. (NASDAQ:OPTN) institutional owners after losing 50% over the past year
|
May 3 |
Will Gain Therapeutics, Inc. (GANX) Report Negative Q1 Earnings? What You Should Know
|
May 2 |
Will OptiNose (OPTN) Report Negative Q1 Earnings? What You Should Know
|
Apr 25 |
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
|
Apr 25 |
Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quarter 2024 XHANCE Net Revenue of $14.9 million
|
Apr 6 |
OptiNose (NASDAQ:OPTN) shareholders have endured a 87% loss from investing in the stock five years ago
|